Inhibition of sPLA2 by pBPB treatment had shown the attenuation of certain features of pulmonary fibrosis along with reduction in TGF-β and deposition of extracellular matrix in lung. The gene discussed is PLA2G2A; the disease is pulmonary fibrosis.